Beacon Biosignals Raises $97 Million Series B
2026-04-06
Tweet
BOSTON, MA, Beacon Biosignals announced an extension to its Series B financing, bringing the funding round to $97 million and the company's cumulative funding to over $132 million.
Beacon Biosignals announced an extension to its Series B financing, bringing the funding round to $97 million and the company's cumulative funding to over $132 million. The upsized round includes new investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
